Skip to main content
SpringerLink
Log in

Effects of fentanyl on serotonin syndrome-like behaviors in rats

  • Short Communication
  • Published:
Journal of Anesthesia Aims and scope Submit manuscript

Abstract

Emerging evidence from case reports suggests that fentanyl may precipitate potentially life-threatening serotonin syndrome in patients taking serotonergic drugs. However, the underlying mechanism of the association between serotonin syndrome and fentanyl remains under investigation. We therefore investigated the pharmacological effects of an analgesic dose of fentanyl (0.2 mg/kg) injected subcutaneously (s.c.) on serotonergic toxicity-like responses in rats. Rats were s.c. injected with 0.75 mg/kg 8-OH-DPAT, a full 5-HT1A agonist, as an animal model of serotonin syndrome. The 8-OH-DPAT-treated rats showed well-characterized serotonin syndrome-like behaviors (low body posture, forepaw treading), hyperlocomotion, and decreased body temperature. Rats injected s.c. with fentanyl alone showed no significant changes in any of the parameters measured, while concomitant administration of fentanyl + 8-OH-DPAT resulted in exaggerated 8-OH-DPAT-induced serototoxic responses. A separate dose–response experiment showed that the serototoxic effect of fentanyl was dose-dependent. Pretreatment with naloxone [2.0 mg/kg, intraperitoneal (i.p.) injection], an opioid receptor antagonist, failed to antagonize the fentanyl-induced exaggerated serotonin syndrome-like behaviors. In contrast, pretreatment with WAY-100653, a serotonin 5-HT1A receptor antagonist (0.5 mg/kg, i.p. injection) completely inhibited all responses. Our findings provide preclinical proof-of-concept that an analgesic dose of fentanyl enhances serotonin toxicity, likely via its serotonin-reuptake inhibitory activity, independently of interaction with the opioid receptors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

References

  1. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352:1112–20.

    Article  CAS  PubMed  Google Scholar 

  2. Rastogi R, Swarm RA, Patel TA. Case scenario: opioid association with serotonin syndrome: implications to the practitioners. Anesthesiology. 2011;115:1291–8.

    PubMed  Google Scholar 

  3. Haberzettl R, Bert B, Fink H, Fox MA. Animal models of the serotonin syndrome: a systematic review. Behav Brain Res. 2013;256:328–45.

    Article  CAS  PubMed  Google Scholar 

  4. Ables AZ, Nagubilli R. Prevention, recognition, and management of serotonin syndrome. Am Fam Physician. 2010;81:1139–42.

    PubMed  Google Scholar 

  5. Gillman PK. Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity. Br J Anaesth. 2005;95:434–41.

    Article  CAS  PubMed  Google Scholar 

  6. Altman CS, Jahangiri MF. Serotonin syndrome in the perioperative period. Anesth Analg. 2010;110:526–8.

    Article  PubMed  Google Scholar 

  7. Greenier E, Lukyanova V, Reede L. Serotonin syndrome: fentanyl and selective serotonin reuptake inhibitor interactions. AANA J. 2014;82:340–5.

    PubMed  Google Scholar 

  8. Health Canada. Fentanyl and serotonin syndrome. Canadian Adverse Reaction Newsletter. 2012; 22(2). Available at: http://www.hc-sc.gc.ca/dhp-mps/medeff/bulletin/carn-bcei_v22n2-eng.php.

  9. Koury KM, Tsui B, Gulur P. Incidence of serotonin syndrome in patients treated with fentanyl on serotonergic agents. Pain Physician. 2015;18:E27–30.

    PubMed  Google Scholar 

  10. Kawano T, Takahashi T, Kaminaga S, Kadono T, Yamanaka D, Iwata H, Eguchi S, Yokoyama M. A comparison of midazolam and dexmedetomidine for the recovery of serotonin syndrome in rats. J Anesth. 2015;29:631–4.

    Article  PubMed  Google Scholar 

  11. Campos AR, Santos FA, Rao VS. Ketamine-induced potentiation of morphine analgesia in rat tail-flick test: role of opioid-, α2-adrenoceptors and ATP-sensitive potassium channels. Biol Pharm Bull. 2006;29:86–9.

    Article  CAS  PubMed  Google Scholar 

  12. Paquette MA, Foley K, Brudney EG, Meshul CK, Johnson SW, Berger SP. The sigma-1 antagonist BMY-14802 inhibits L-DOPA-induced abnormal involuntary movements by a WAY-100635-sensitive mechanism. Psychopharmacology. 2009;204:743–54.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  13. Spanos LJ, Yamamoto BK. Acute and subchronic effects of methylenedioxymethamphetamine [(±)MDMA] on locomotion and serotonin syndrome behavior in the rat. Pharmacol Biochem Behav. 1989;32:835–40.

    Article  CAS  PubMed  Google Scholar 

  14. Gnanadesigan N, Espinoza RT, Smith R, Israel M, Reuben DB. Interaction of serotonergic antidepressants and opioid analgesics: is serotonin syndrome going undetected? J Am Med Dir Assoc. 2005;6:265–9.

    Article  PubMed  Google Scholar 

  15. Nisijima K, Yoshino T, Yui K, Katoh S. Potent serotonin (5-HT)(2A) receptor antagonists completely prevent the development of hyperthermia in an animal model of the 5-HT syndrome. Brain Res. 2001;890:23–31.

    Article  CAS  PubMed  Google Scholar 

  16. Gudjonsson SV. The body temperature in rats on normal and deficient diets: preliminary report. J Physiol. 1932;74:73–80.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anesthesiology and Intensive Care Medicine, Kochi Medical School, Kohasu, Oko-cho, Nankoku, Kochi, 783-8505, Japan

    Sonoe Kitamura, Takashi Kawano, Satomi Kaminaga, Daiki Yamanaka, Hiroki Tateiwa, Fabricio M. Locatelli & Masataka Yokoyama

Authors
  1. Sonoe Kitamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takashi Kawano
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Satomi Kaminaga
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Daiki Yamanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hiroki Tateiwa
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Fabricio M. Locatelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Masataka Yokoyama
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Takashi Kawano.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 312 kb)

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kitamura, S., Kawano, T., Kaminaga, S. et al. Effects of fentanyl on serotonin syndrome-like behaviors in rats. J Anesth 30, 178–182 (2016). https://doi.org/10.1007/s00540-015-2092-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00540-015-2092-y

Keywords

Search

Navigation